MARKET

OPK

OPK

Opko Health
NASDAQ
1.240
-0.020
-1.59%
After Hours: 1.260 +0.02 +1.61% 19:54 05/09 EDT
OPEN
1.260
PREV CLOSE
1.260
HIGH
1.280
LOW
1.210
VOLUME
3.72M
TURNOVER
--
52 WEEK HIGH
2.035
52 WEEK LOW
1.150
MARKET CAP
983.39M
P/E (TTM)
-21.0169
1D
5D
1M
3M
1Y
5Y
1D
Healthcare stocks that could be poised for a rebound
Seeking Alpha · 1d ago
Weekly Report: what happened at OPK last week (0428-0502)?
Weekly Report · 5d ago
Piper Sandler Keeps Their Buy Rating on Opko Health (OPK)
TipRanks · 05/02 10:57
OPKO Health First Quarter 2025 Earnings: Misses Expectations
Simply Wall St · 05/02 10:42
OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves
TipRanks · 05/02 01:00
OPKO Health Price Target Maintained With a $2.25/Share by Barrington Research
Dow Jones · 05/01 18:30
OPKO Health Is Maintained at Outperform by Barrington Research
Dow Jones · 05/01 18:30
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
Benzinga · 05/01 18:20
More
About OPK
More
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Recently
Symbol
Price
%Change

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.